Hernigou, P.; Homma, Y.; Hernigou, J.; Flouzat Lachaniette, C.H.; Rouard, H.; Verrier, S.
Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips. Cells 2024, 13, 776.
https://doi.org/10.3390/cells13090776
AMA Style
Hernigou P, Homma Y, Hernigou J, Flouzat Lachaniette CH, Rouard H, Verrier S.
Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips. Cells. 2024; 13(9):776.
https://doi.org/10.3390/cells13090776
Chicago/Turabian Style
Hernigou, Philippe, Yasuhiro Homma, Jacques Hernigou, Charles Henri Flouzat Lachaniette, Helène Rouard, and Sophie Verrier.
2024. "Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips" Cells 13, no. 9: 776.
https://doi.org/10.3390/cells13090776
APA Style
Hernigou, P., Homma, Y., Hernigou, J., Flouzat Lachaniette, C. H., Rouard, H., & Verrier, S.
(2024). Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips. Cells, 13(9), 776.
https://doi.org/10.3390/cells13090776
